RAP 0.00% 20.5¢ resapp health limited

Australia-China Biotech Invest 2017, page-9

  1. 1,426 Posts.
    lightbulb Created with Sketch. 1264
    It would be interesting for how they negotiate contracts with telehealth. $10 per use is great for diagnosing pneumonia. And ongoing asthma maintenance. But just imagine if the app were eventually able to diagnose TB or lung cancer. I would have thought that would be worth more than $10.
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.